Invention Grant
US07988994B2 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
有权
吡非尼酮和药学上可接受的赋形剂的胶囊制剂
- Patent Title: Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
- Patent Title (中): 吡非尼酮和药学上可接受的赋形剂的胶囊制剂
-
Application No.: US12067712Application Date: 2006-09-22
-
Publication No.: US07988994B2Publication Date: 2011-08-02
- Inventor: Ramachandran Radhakrishnan , Ronald Vladyka , Kenneth Sultzbaugh
- Applicant: Ramachandran Radhakrishnan , Ronald Vladyka , Kenneth Sultzbaugh
- Applicant Address: US CA Brisbane
- Assignee: Intermune, Inc.
- Current Assignee: Intermune, Inc.
- Current Assignee Address: US CA Brisbane
- Agency: Marshall, Gerstein & Borun LLP
- Agent John A. Bendrick
- International Application: PCT/US2006/037057 WO 20060922
- International Announcement: WO2007/038315 WO 20070405
- Main IPC: A61K9/48
- IPC: A61K9/48 ; A61K9/14 ; A01N43/40
Abstract:
A capsule formulation of pirfenidone is provided that includes pharmaceutically acceptable excipients. In one embodiment, this capsule formulation is capable of sustaining desirable pharmacokinetic responses in a patient. Further provided are methods of treating fibrotic conditions and other cytokine-mediated disorders by administering pirfenidone capsules of such formulation to a patient in need.
Public/Granted literature
- US20100152250A1 CAPSULE FORMULATION OF PIRFENIDONE AND PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS Public/Granted day:2010-06-17
Information query
